Does TOPOTECAN Cause Rhabdomyosarcoma recurrent? 10 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Rhabdomyosarcoma recurrent have been filed in association with TOPOTECAN (HYCAMTIN). This represents 0.3% of all adverse event reports for TOPOTECAN.
10
Reports of Rhabdomyosarcoma recurrent with TOPOTECAN
0.3%
of all TOPOTECAN reports
2
Deaths
0
Hospitalizations
How Dangerous Is Rhabdomyosarcoma recurrent From TOPOTECAN?
Of the 10 reports, 2 (20.0%) resulted in death.
Is Rhabdomyosarcoma recurrent Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOPOTECAN. However, 10 reports have been filed with the FAERS database.
What Other Side Effects Does TOPOTECAN Cause?
Febrile neutropenia (425)
Off label use (390)
Death (332)
Product use in unapproved indication (323)
Neutropenia (255)
Pyrexia (252)
Anaemia (242)
Malignant neoplasm progression (238)
Drug ineffective (216)
Disease progression (207)
What Other Drugs Cause Rhabdomyosarcoma recurrent?
CYCLOPHOSPHAMIDE (19)
IFOSFAMIDE (19)
VINCRISTINE (18)
ETOPOSIDE (17)
DOXORUBICIN (14)
CARBOPLATIN (12)
DACTINOMYCIN (12)
IRINOTECAN (12)
IDARUBICIN (9)
TROFOSFAMIDE (9)
Which TOPOTECAN Alternatives Have Lower Rhabdomyosarcoma recurrent Risk?
TOPOTECAN vs TOPOTECAN\TOPOTECAN
TOPOTECAN vs TOPROL
TOPOTECAN vs TOREMIFENE
TOPOTECAN vs TORIPALIMAB
TOPOTECAN vs TORSEMIDE